Method Validation for New Nitrogen/Sulfur Species Analysis Techniques

Sponsor
University of Southampton (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03512535
Collaborator
(none)
220
1
81.1
2.7

Study Details

Study Description

Brief Summary

Plasma redox status is well known to alter with age but previously differences have only been reported for two specific redox couples; reduced and oxidized cysteine and reduced and oxidized glutathione. (Jones DP, Rejuvenation Res. 2006) The overall aim of this project is to develop new methods to determine how other Reactive Nitrogen and Sulfur species, such as free and protein-bound thiols (organic compounds that contain a Sulfhydryl group, -SH) and Hydrogen Sulfide (H2S) change with age and gender in a medium-sized cohort of healthy individuals (n=100 of either sex; age 18-70).

Our group has recently developed a novel analytical platform to measure thiol-containing compounds in biological samples that is based on the reaction with the thiol-alkylating agent N-ethylmaleimide (NEM). We have used this chemical for years as stabilisation agent in other analyses to quantify Nitric Oxide metabolites.(Feelisch et al, FASEB 2002 and Levett et al, Sci Rep 2011) We now wish to develop a similar method to measure thiol containing compounds using a novel rapid LC-MS/MS based technology for screening large numbers of individuals.

The project will therefore have 2 stages:
  1. Initial method development will require occasional use of whole blood, plasma and red blood cells to establishing optimal conditions. E.g. to compare heparin and EDTA as anticoagulants to serum; investigate effects of temperature and pH; identify optimal concentration of derivatisation/reduction agents and optimal reaction times.

  2. We then aim to establish the normal distribution of these novel compounds across healthy individuals of different gender and varying ages.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    220 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Method Validation for New Nitrogen/Sulfur Species Analysis Techniques
    Actual Study Start Date :
    Jan 29, 2018
    Anticipated Primary Completion Date :
    Nov 1, 2024
    Anticipated Study Completion Date :
    Nov 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    Stage 1

    Samples from up to 20 participants will be used to finalise the analytical methods

    Stage 2

    Samples from up to 200 participants will be used to then validate the normal ranges of these markers across different age ranges in both genders

    Outcome Measures

    Primary Outcome Measures

    1. Concentration of reactive (nitrogen or sulfur containing) species [Baseline]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Aged 18 years or above

    • Currently healthy (i.e. no inter-current illness/infection)

    • Capacity and ability to give written informed consent

    Exclusion Criteria:
    • Current or previous smoker

    • Other medical co-morbidity (e.g. hypertension, diabetes, asthma, COPD, cardiovascular disease, current or previous malignant disease etc.)

    • Surgery within previous 28 days

    • Excessive alcohol intake (i.e above UK's recommended intake limit of 14 units per week).

    • Pregnant or currently breast-feeding

    • On current medication

    • Taken vitamins / minerals / herbal remedies within previous 28 days

    • Difficult venous access

    • Needle phobia

    • Participating in another similar/conflicting research study already

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Southampton Southampton Hampshire United Kingdom SO16 6YD

    Sponsors and Collaborators

    • University of Southampton

    Investigators

    • Study Chair: Martin Feelisch, PhD, University of Southampton

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Southampton
    ClinicalTrials.gov Identifier:
    NCT03512535
    Other Study ID Numbers:
    • 31426
    First Posted:
    Apr 30, 2018
    Last Update Posted:
    Mar 24, 2021
    Last Verified:
    Mar 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Mar 24, 2021